2021: A Year in Review by Manica Balasegaram
17 Dec 2021

2021: A Year in Review by Manica Balasegaram

If the arrival of COVID-19 represented a tragic and profound disruption to every facet of our lives, then 2021 has demonstrated the remarkable progress that can be achieved through global investment in the research and development of diagnostics, vaccines and treatments. At the same time, the appearance of new COVID variants has driven home the urgency of ensuring equitable access to health measures for all people, everywhere. These lessons have made the importance of our mission even more apparent as we’ve pushed forward throughout 2021 with the development of new treatments to tackle the silent pandemic of drug-resistant infection

Read more
We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.